Zinc reverses malathion-induced impairment in antioxidant defenses

Jeferson L Franco1, Thais Posser, Jacó J Mattos

  • 1Departamento de Ciências Fisiológicas, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, SC 88040-900, Brazil.

Toxicology Letters
|May 12, 2009
PubMed

Insights

Zinc supplementation protected rats against malathion toxicity by restoring antioxidant enzyme activity. This study highlights zinc

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • Malathion toxicity involves acetylcholinesterase inhibition and oxidative stress.
  • Zinc exhibits neuroprotective properties in various studies.
  • Understanding malathion's non-cholinergic effects and zinc's counteracting mechanisms is crucial.

Purpose of the Study:

  • To investigate the neuroprotective effects of zinc chloride against acute malathion toxicity in rats.
  • To examine malathion's impact on hippocampal acetylcholinesterase and antioxidant enzymes.
  • To explore zinc's influence on heat shock protein expression.

Main Methods:

  • Adult male Wistar rats were treated with zinc chloride for 30 days.
  • Acute malathion exposure was administered (250mg/kg, i.p.).
  • Hippocampal acetylcholinesterase activity, antioxidant enzyme levels, and heat shock protein expression (HSP60, HSP70) were measured.

Main Results:

  • Malathion significantly decreased hippocampal acetylcholinesterase and key antioxidant enzyme activities.
  • Zinc pretreatment fully restored antioxidant enzyme activity but only partially improved acetylcholinesterase levels.
  • Zinc administration increased HSP60 expression, suggesting a novel protective pathway.

Conclusions:

  • Inhibition of antioxidant enzymes is a significant non-cholinergic effect of malathion.
  • Oral zinc treatment can effectively rescue these compromised antioxidant defenses.
  • Zinc's neuroprotective action may involve preserving antioxidant capacity and inducing HSP60.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...